W. D. Besten

发表

Sherr-null lymphoblastic leukemia Arf , + Cytokine-dependent imatinib resistance in mouse BCR-ABL

R. Williams, J. Charles, W. D. Besten, 2007 .

Developmental and biochemical characterization of activators of the RB and p53 tumor suppressor pathways

W. D. Besten, D. Besten, 2007 .

Myeloid Leukemia-Associated Nucleophosmin Mutants Perturb p53-Dependent and Independent Activities of the Arf Tumor Suppressor Protein

C. Sherr, R. Williams, M. Kuo, 2005, Cell cycle.

NEDD 8 links Cullin – Ring ubiquitin Ligase function to the p 97 pathway

R. Deshaies, G. Kleiger, R. Verma, 2013 .

Arf Induces p 53-dependent and-independent Antiproliferative Genes 1 , 2

M. Roussel, D. Pei, Cheng Cheng, 2003 .

Michael Ubiquitin Ligase HERC 2 Enzyme USP 33 Is Mediated by p 97 and the Degradation of the Deubiquitinating Protein Synthesis and Degradation

Michael J. Sweredoski, R. Deshaies, D. Chan, 2014 .

N-Terminal Polyubiquitination of the ARF Tumor Suppressor, A Natural Lysine-Less Protein

C. Sherr, M. Kuo, W. D. Besten, 2004, Cell cycle.

Primary Amine Tethered Small Molecules Promote the Degradation of X-Linked Inhibitor of Apoptosis Protein.

Melinda M. Mulvihill, I. Wertz, W. Fairbrother, 2021, Journal of the American Chemical Society.

p53-Dependent and -independent functions of the Arf tumor suppressor.

F. Zindy, M. Roussel, C. Sherr, 2005, Cold Spring Harbor symposia on quantitative biology.

Engineering ERα degraders with pleiotropic ubiquitin ligase ligands maximizes therapeutic efficacy by co-opting distinct effector ligases

Melinda M. Mulvihill, K. Nagapudi, Elisia Villemure, 2024, bioRxiv.